Study S001120

A Study of HS-20094 Versus Dulaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabete

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07156539
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 546
Start: 2025-09-30
Primary completion: 2027-03-30
Lead sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:HS-20094 Injection; DRUG:Dulaglutide Injection
Results posted: FALSE

Registered primary outcomes

Change in HbA1c [Week 0 to Week 44]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.